Cellular Stress in Dry Eye Disease—Key Hub of the Vicious Circle
Abstract
:Simple Summary
Abstract
1. Introduction
2. The Power of Surface Stress: The Pathophysiological Footprint and Impact
3. Cellular Stress—Definition and Effects
4. Stress Management at the Ocular Surface and Recovery
5. Recovery from Stress and Stress-Related Changes
6. Conclusions and Outlook
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Van Setten, G.-B. Ocular Surface Allostasis—When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience. Biomolecules 2023, 13, 1246. [Google Scholar] [CrossRef] [PubMed]
- Van Setten, G.-B. Attrition und Osmokinetik—Zwei Konzepte zur Pathogenese des Trockenen Auges. Spektrum Augenheilkd. 2021, 35, 150–158. [Google Scholar] [CrossRef]
- Pflugfelder, S.C.; Stern, M.E. Biological functions of tear film. Exp. Eye Res. 2020, 197, 108115. [Google Scholar] [CrossRef]
- Tiffany, J.M. The normal tear film. Dev. Ophthalmol. 2008, 41, 1–20. [Google Scholar] [CrossRef] [PubMed]
- Baudouin, C.; Rolando, M.; Benitez Del Castillo, J.M.; Messmer, E.M.; Figueiredo, F.C.; Irkec, M.; Van Setten, G.; Labetoulle, M. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog. Retin. Eye Res. 2019, 71, 68–87. [Google Scholar] [CrossRef] [PubMed]
- Argüeso, P. Human ocular mucins: The endowed guardians of sight. Adv. Drug Deliv. Rev. 2021, 180, 114074. [Google Scholar] [CrossRef]
- Dhabhar, F.S. Effects of stress on immune function: The good, the bad, and the beautiful. Immunol. Res. 2014, 58, 193–210. [Google Scholar] [CrossRef]
- McMonnies, C.W. Why the symptoms and objective signs of dry eye disease may not correlate. J. Optom. 2021, 14, 3–10. [Google Scholar] [CrossRef]
- Guan, B.J.; van Hoef, V.; Jobava, R.; Elroy-Stein, O.; Valasek, L.S.; Cargnello, M.; Gao, X.H.; Krokowski, D.; Merrick, W.C.; Kimball, S.R.; et al. A Unique ISR Program Determines Cellular Responses to Chronic Stress. Mol. Cell 2017, 68, 885–900.e6. [Google Scholar] [CrossRef]
- Fulda, S.; Gorman, A.M.; Hori, O.; Samali, A. Cellular Stress Responses: Cell Survival and Cell Death. Int. J. Cell Biol. 2010, 2010, 214074. [Google Scholar] [CrossRef]
- Van Setten, G.; Labetoulle, M.; Baudouin, C.; Rolando, M. Evidence of seasonality and effects of psychrometry in dry eye disease. Acta Ophthalmol. 2016, 94, 499–506. [Google Scholar] [CrossRef] [PubMed]
- Ehlers, N.; Heegaard, S.; Hjortdal, J.; Ivarsen, A.; Nielsen, K.; Prause, J.U. Morphological evaluation of normal human corneal epithelium. Acta Ophthalmol. 2010, 88, 858–861. [Google Scholar] [CrossRef] [PubMed]
- Lemp, M.A.; Mathers, W.D. Corneal epithelial cell movement in humans. Eye 1989, 3 Pt 4, 438–445. [Google Scholar] [CrossRef]
- Lu, L.; Reinach, P.S.; Kao, W.W. Corneal epithelial wound healing. Exp. Biol. Med. 2001, 226, 653–664. [Google Scholar] [CrossRef] [PubMed]
- Ren, H.; Wilson, G. The cell shedding rate of the corneal epithelium—A comparison of collection methods. Curr. Eye Res. 1996, 15, 1054–1059. [Google Scholar] [CrossRef] [PubMed]
- Ren, H.; Wilson, G. The effect of a shear force on the cell shedding rate of the corneal epithelium. Acta Ophthalmol. Scand. 1997, 75, 383–387. [Google Scholar] [CrossRef]
- Yazdanpanah, G.; Jabbehdari, S.; Djalilian, A.R. Limbal and corneal epithelial homeostasis. Curr. Opin. Ophthalmol. 2017, 28, 348–354. [Google Scholar] [CrossRef]
- Montanino, A.; Pandolfi, A. The inclusion of the epithelium in numerical models of the human cornea. Biomech. Model. Mechanobiol. 2024, 23, 709–720. [Google Scholar] [CrossRef]
- Edorh, N.A.; El Maftouhi, A.; Djerada, Z.; Arndt, C.; Denoyer, A. New model to better diagnose dry eye disease integrating OCT corneal epithelial mapping. Br. J. Ophthalmol. 2022, 106, 1488–1495. [Google Scholar] [CrossRef]
- Van Setten, G.B. Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered. Int. J. Mol. Sci. 2020, 21, 4333. [Google Scholar] [CrossRef]
- Craig, J.P.; Nichols, K.K.; Akpek, E.K.; Caffery, B.; Dua, H.S.; Joo, C.K.; Liu, Z.; Nelson, J.D.; Nichols, J.J.; Tsubota, K.; et al. TFOS DEWS II Definition and Classification Report. Ocul. Surf. 2017, 15, 276–283. [Google Scholar] [CrossRef]
- Baudouin, C. A new approach for better comprehension of diseases of the ocular surface. J. Fr. D’ophtalmologie 2007, 30, 239–246. [Google Scholar] [CrossRef]
- Baudouin, C.; Messmer, E.M.; Aragona, P.; Geerling, G.; Akova, Y.A.; Benítez-del-Castillo, J.; Boboridis, K.G.; Merayo-Lloves, J.; Rolando, M.; Labetoulle, M. Revisiting the vicious circle of dry eye disease: A focus on the pathophysiology of meibomian gland dysfunction. Br. J. Ophthalmol. 2016, 100, 300–306. [Google Scholar] [CrossRef] [PubMed]
- Lu, S.; Wei, F.; Li, G. The evolution of the concept of stress and the framework of the stress system. Cell Stress 2021, 5, 76–85. [Google Scholar] [CrossRef]
- Baudouin, C.; Irkeç, M.; Messmer, E.M.; Benítez-Del-Castillo, J.M.; Bonini, S.; Figueiredo, F.C.; Geerling, G.; Labetoulle, M.; Lemp, M.; Rolando, M.; et al. Clinical impact of inflammation in dry eye disease: Proceedings of the ODISSEY group meeting. Acta Ophthalmol. 2018, 96, 111–119. [Google Scholar] [CrossRef]
- Ho, T.C.; Fan, N.W.; Yeh, S.I.; Chen, S.L.; Tsao, Y.P. The Therapeutic Effects of a PEDF-Derived Short Peptide on Murine Experimental Dry Eye Involves Suppression of MMP-9 and Inflammation. Transl. Vis. Sci. Technol. 2022, 11, 12. [Google Scholar] [CrossRef] [PubMed]
- Lanza, N.L.; Valenzuela, F.; Perez, V.L.; Galor, A. The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye. Ocul. Surf. 2016, 14, 189–195. [Google Scholar] [CrossRef]
- Schargus, M.; Geerling, G.; Joachim, S.C. Significance of New Methods of Examining the Tear Film in Dry Eye Disease: Tear Film Osmolarity and Matrix Metalloproteinases (MMP-9). Klin. Monatsblatter Augenheilkd. 2018, 235, 597–602. [Google Scholar] [CrossRef]
- Soifer, M.; Mousa, H.M.; Stinnett, S.S.; Galor, A.; Perez, V.L. Matrix metalloproteinase 9 positivity predicts long term decreased tear production. Ocul. Surf. 2021, 19, 270–274. [Google Scholar] [CrossRef] [PubMed]
- Alves, M.; Novaes, P.; Morraye Mde, A.; Reinach, P.S.; Rocha, E.M. Is dry eye an environmental disease? Arq. Bras. Oftalmol. 2014, 77, 193–200. [Google Scholar] [CrossRef]
- Liu, H.; Sheng, M.; Liu, Y.; Wang, P.; Chen, Y.; Chen, L.; Wang, W.; Li, B. Expression of SIRT1 and oxidative stress in diabetic dry eye. Int. J. Clin. Exp. Pathol. 2015, 8, 7644–7653. [Google Scholar]
- Pflugfelder, S.C.; de Paiva, C.S. The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology 2017, 124, S4–S13. [Google Scholar] [CrossRef]
- Qian, L.; Wei, W. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS ONE 2022, 17, e0271267. [Google Scholar] [CrossRef]
- Seen, S.; Tong, L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018, 96, e412–e420. [Google Scholar] [CrossRef] [PubMed]
- Navel, V.; Sapin, V.; Henrioux, F.; Blanchon, L.; Labbé, A.; Chiambaretta, F.; Baudouin, C.; Dutheil, F. Oxidative and antioxidative stress markers in dry eye disease: A systematic review and meta-analysis. Acta Ophthalmol. 2022, 100, 45–57. [Google Scholar] [CrossRef] [PubMed]
- Bron, A.J.; de Paiva, C.S.; Chauhan, S.K.; Bonini, S.; Gabison, E.E.; Jain, S.; Knop, E.; Markoulli, M.; Ogawa, Y.; Perez, V.; et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 2017, 15, 438–510. [Google Scholar] [CrossRef]
- Böhm, E.W.; Buonfiglio, F.; Voigt, A.M.; Bachmann, P.; Safi, T.; Pfeiffer, N.; Gericke, A. Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biol. 2023, 68, 102967. [Google Scholar] [CrossRef] [PubMed]
- Dogru, M.; Kojima, T.; Simsek, C.; Tsubota, K. Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease. Investig. Ophthalmol. Vis. Sci. 2018, 59, DES163–DES168. [Google Scholar] [CrossRef]
- Gilbard, J.P.; Farris, R.L. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch. Ophthalmol. 1979, 97, 1642–1646. [Google Scholar] [CrossRef]
- Murube, J. Tear osmolarity. Ocul. Surf. 2006, 4, 62–73. [Google Scholar] [CrossRef]
- Warcoin, E.; Clouzeau, C.; Brignole-Baudouin, F.; Baudouin, C. Hyperosmolarity: Intracellular effects and implication in dry eye disease. J. Fr. d’Ophtalmologie 2016, 39, 641–651. [Google Scholar] [CrossRef] [PubMed]
- Van Setten, G.B. Growth Factors in Dry Eye Disease. In Ciba Vision Symposium; Dry Eye. A systematic approach to therapy. Murube del Castillo, J., Rolando, M., Eds.; Tecnimedia SL, Madrid, Spain, 1999; pp. 51–60.
- Van Setten, G.B. Coping mechanisms of the Ocular Surface to Dessication Challenges. In Ophthalmic Fiction Workshop; Coronis Foundation: Munich, Germany, 2021. [Google Scholar]
- Bron, A.J.; Dogru, M.; Horwath-Wimter, J.; Kojima, T.; Kovács, I.; Müller-Lierheim, W.G.K.; van Setten, G.B.; Belmonte, C. Reflections on the Ocular Surface: Summary of the Presentations at the 4th Coronis Foundation Ophthalmic Symposium Debate: “A Multifactorial Approach to Ocular Surface Disorders” (August 31 2021). Front. Biosci.-Landmark 2022, 27, 142. [Google Scholar] [CrossRef] [PubMed]
- Pakos-Zebrucka, K.; Koryga, I.; Mnich, K.; Ljujic, M.; Samali, A.; Gorman, A.M. The integrated stress response. EMBO Rep. 2016, 17, 1374–1395. [Google Scholar] [CrossRef] [PubMed]
- Maxwell, B.A.; Gwon, Y.; Mishra, A.; Peng, J.; Nakamura, H.; Zhang, K.; Kim, H.J.; Taylor, J.P. Ubiquitination is essential for recovery of cellular activities after heat shock. Science 2021, 372, eabc3593. [Google Scholar] [CrossRef] [PubMed]
- Van Setten, G.-B. The Anatomical Dry Eye—A Different Form of Ocular Surface Disease Deserves Focus. Open J. Ophthalmol. 2017, 7, 184–190. [Google Scholar] [CrossRef]
- Van Setten, G. Epitheliopathy of the bleb (EoB)-identifying attrition: A new model for failure of glaucoma surgery. New Front. Ophthalmol. 2018, 4, 1–4. [Google Scholar] [CrossRef]
- Van Setten, G.B. Osmokinetics: Defining the Characteristics of Osmotic Challenge to the Ocular Surface. Klin. Monatsblatter Augenheilkd. 2020, 237, 644–648. [Google Scholar] [CrossRef]
- Van Setten, G.B.; Mueller-Lierheim, W.; Baudouin, C. Dry Eye Etiology: Focus on Friction. Klin. Monatsblatter Augenheilkd. 2020, 237, 1235–1236. [Google Scholar] [CrossRef]
- Bron, A.J. Diagnosis of dry eye. Surv. Ophthalmol. 2001, 45 (Suppl. S2), S221–S226. [Google Scholar] [CrossRef]
- Bron, A.J.; Evans, V.E.; Smith, J.A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003, 22, 640–650. [Google Scholar] [CrossRef]
- Van Setten, G. Sandbank Epitheliopathy of the Conjunctiva (SEC) A New Indicator in Dry Eye Diagnostics Useful for Optimized Ocular Surgery. J. Eye Cataract. Surg. 2017, 3, 29. [Google Scholar] [CrossRef]
- Sullivan, B.D.; Crews, L.A.; Messmer, E.M.; Foulks, G.N.; Nichols, K.K.; Baenninger, P.; Geerling, G.; Figueiredo, F.; Lemp, M.A. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications. Acta Ophthalmol. 2014, 92, 161–166. [Google Scholar] [CrossRef] [PubMed]
- Belmonte, C.; Nichols, J.J.; Cox, S.M.; Brock, J.A.; Begley, C.G.; Bereiter, D.A.; Dartt, D.A.; Galor, A.; Hamrah, P.; Ivanusic, J.J.; et al. TFOS DEWS II pain and sensation report. Ocul. Surf. 2017, 15, 404–437. [Google Scholar] [CrossRef]
- Eom, H.D.; Jung, J.U.; Lee, K.P.; Kim, J.; Yoon, D.H.; Kim, M.J.; Son, B.J.; Kim, H.K. Simplified Classification of Tear Film Break-Up Patterns and Their Clinicopathological Correlations in Patients with Dry Eye Disease. Eye Contact Lens 2021, 47, 15–19. [Google Scholar] [CrossRef]
- Nichols, J.J.; Nichols, K.K.; Puent, B.; Saracino, M.; Mitchell, G.L. Evaluation of tear film interference patterns and measures of tear break-up time. Optom. Vis. Sci. 2002, 79, 363–369. [Google Scholar] [CrossRef]
- Takahashi, Y.; Lee, P.A.L.; Vaidya, A.; Kono, S.; Kakizaki, H. Tear film break-up patterns in thyroid eye disease. Sci. Rep. 2021, 11, 5288. [Google Scholar] [CrossRef]
- Knop, E.; Knop, N. Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system. Ophthalmol. Z. Dtsch. Ophthalmol. Ges. 2003, 100, 929–942. [Google Scholar] [CrossRef]
- Knop, N.; Knop, E. Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT). Dev. Ophthalmol. 2010, 45, 23–39. [Google Scholar] [CrossRef]
- Mastropasqua, R.; Agnifili, L.; Fasanella, V.; Nubile, M.; Gnama, A.A.; Falconio, G.; Perri, P.; Di Staso, S.; Mariotti, C. The Conjunctiva-Associated Lymphoid Tissue in Chronic Ocular Surface Diseases. Microsc. Microanal. 2017, 23, 697–707. [Google Scholar] [CrossRef]
- Steven, P.; Schwab, S.; Kiesewetter, A.; Saban, D.R.; Stern, M.E.; Gehlsen, U. Disease-Specific Expression of Conjunctiva Associated Lymphoid Tissue (CALT) in Mouse Models of Dry Eye Disease and Ocular Allergy. Int. J. Mol. Sci. 2020, 21, 7514. [Google Scholar] [CrossRef]
- Knop, E.; Knop, N.; Brewitt, H. Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease. Ophthalmol. Z. Dtsch. Ophthalmol. Ges. 2003, 100, 917–928. [Google Scholar] [CrossRef]
- Van Setten, G.B. Osmokinetics: A new dynamic concept in dry eye disease. J. Fr. D’ophtalmologie 2019, 42, 221–225. [Google Scholar] [CrossRef] [PubMed]
- Tomlinson, A.; Khanal, S.; Ramaesh, K.; Diaper, C.; McFadyen, A. Tear film osmolarity: Determination of a referent for dry eye diagnosis. Investig. Ophthalmol. Vis. Sci. 2006, 47, 4309–4315. [Google Scholar] [CrossRef]
- Watanabe, K.; Morishita, K.; Zhou, X.; Shiizaki, S.; Uchiyama, Y.; Koike, M.; Naguro, I.; Ichijo, H. Cells recognize osmotic stress through liquid-liquid phase separation lubricated with poly(ADP-ribose). Nat. Commun. 2021, 12, 1353. [Google Scholar] [CrossRef]
- Saikia, M.; Jobava, R.; Parisien, M.; Putnam, A.; Krokowski, D.; Gao, X.H.; Guan, B.J.; Yuan, Y.; Jankowsky, E.; Feng, Z.; et al. Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress. Mol. Cell. Biol. 2014, 34, 2450–2463. [Google Scholar] [CrossRef] [PubMed]
- Dmitrieva, N.I.; Michea, L.F.; Rocha, G.M.; Burg, M.B. Cell cycle delay and apoptosis in response to osmotic stress. Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 2001, 130, 411–420. [Google Scholar] [CrossRef]
- Copp, J.; Wiley, S.; Ward, M.W.; van der Geer, P. Hypertonic shock inhibits growth factor receptor signaling, induces caspase-3 activation, and causes reversible fragmentation of the mitochondrial network. Am. J. Physiol. Cell Physiol. 2005, 288, C403–C415. [Google Scholar] [CrossRef]
- Bron, A.J.; Willshire, C. Tear Osmolarity in the Diagnosis of Systemic Dehydration and Dry Eye Disease. Diagnostics 2021, 11, 387. [Google Scholar] [CrossRef]
- Baum, J. A relatively dry eye during sleep. Cornea 1990, 9, 1. [Google Scholar] [CrossRef]
- Guillon, M.; Shah, S. Rationale for 24-hour management of dry eye disease: A review. Contact Lens Anterior Eye J. Br. Contact Lens Assoc. 2019, 42, 147–154. [Google Scholar] [CrossRef]
- Takahashi, A.; Negishi, K.; Ayaki, M.; Uchino, M.; Tsubota, K. Nocturnal Lagophthalmos and Sleep Quality in Patients with Dry Eye Disease. Life 2020, 10, 105. [Google Scholar] [CrossRef]
- Murube, J. REM sleep: Tear secretion and dreams. Ocul. Surf. 2008, 6, 2–8. [Google Scholar] [CrossRef] [PubMed]
- Kitazawa, M.; Sakamoto, C.; Yoshimura, M.; Kawashima, M.; Inoue, S.; Mimura, M.; Tsubota, K.; Negishi, K.; Kishimoto, T. The Relationship of Dry Eye Disease with Depression and Anxiety: A Naturalistic Observational Study. Transl. Vis. Sci. Technol. 2018, 7, 35. [Google Scholar] [CrossRef] [PubMed]
- Gosheger, G.; Hardes, J.; Ahrens, H.; Streitburger, A.; Buerger, H.; Erren, M.; Gunsel, A.; Kemper, F.H.; Winkelmann, W.; Von Eiff, C. Silver-coated megaendoprostheses in a rabbit model—An analysis of the infection rate and toxicological side effects. Biomaterials 2004, 25, 5547–5556. [Google Scholar] [CrossRef] [PubMed]
- Puri, S.; Coulson-Thomas, Y.M.; Gesteira, T.F.; Coulson-Thomas, V.J. Distribution and Function of Glycosaminoglycans and Proteoglycans in the Development, Homeostasis and Pathology of the Ocular Surface. Front. Cell Dev. Biol. 2020, 8, 731. [Google Scholar] [CrossRef] [PubMed]
- Li, K.X.; Loshak, H. CADTH Rapid Response Reports. In Pilocarpine for Medication-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines; Canadian Agency for Drugs and Technologies in Health: Ottawa, ON, Canada, 2019. [Google Scholar]
- Postnikoff, C.K.; Nichols, K.K. Neutrophil and T-Cell Homeostasis in the Closed Eye. Investig. Ophthalmol. Vis. Sci. 2017, 58, 6212–6220. [Google Scholar] [CrossRef]
- Rossi, C.; Fernàndez, A.; Torres, P.; Ramirez-Nuñez, O.; Granado-Serrano, A.B.; Fontdevila, L.; Povedano, M.; Pamplona, R.; Ferrer, I.; Portero-Otin, M. Cell Stress Induces Mislocalization of Transcription Factors with Mitochondrial Enrichment. Int. J. Mol. Sci. 2021, 22, 8853. [Google Scholar] [CrossRef]
- Sheng, X.; Xia, Z.; Yang, H.; Hu, R. The ubiquitin codes in cellular stress responses. Protein Cell 2024, 15, 157–190. [Google Scholar] [CrossRef]
- Dantuma, N.P.; Lindsten, K. Stressing the ubiquitin-proteasome system. Cardiovasc. Res. 2010, 85, 263–271. [Google Scholar] [CrossRef]
- Menéndez-Benito, V.; Verhoef, L.G.; Masucci, M.G.; Dantuma, N.P. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum. Mol. Genet. 2005, 14, 2787–2799. [Google Scholar] [CrossRef]
- Christianson, J.C.; Ye, Y. Cleaning up in the endoplasmic reticulum: Ubiquitin in charge. Nat. Struct. Mol. Biol. 2014, 21, 325–335. [Google Scholar] [CrossRef]
- Varshavsky, A. The Ubiquitin System, Autophagy, and Regulated Protein Degradation. Annu. Rev. Biochem. 2017, 86, 123–128. [Google Scholar] [CrossRef] [PubMed]
- Kültz, D. Osmotic stress sensing and signaling in animals. FEBS J. 2007, 274, 5781. [Google Scholar] [CrossRef]
- Kültz, D.; Burg, M.B. Intracellular signaling in response to osmotic stress. Contrib. Nephrol. 1998, 123, 94–109. [Google Scholar] [CrossRef]
- Guindolet, D.; Woodward, A.M.; Gabison, E.E.; Argüeso, P. Alleviation of Endoplasmic Reticulum Stress Enhances Human Corneal Epithelial Cell Viability under Hyperosmotic Conditions. Int. J. Mol. Sci. 2022, 23, 4528. [Google Scholar] [CrossRef]
- Williams, T.D.; Rousseau, A. Translation regulation in response to stress. FEBS J. 2024; epub ahead of print. [Google Scholar] [CrossRef]
- Jobava, R.; Mao, Y.; Guan, B.J.; Hu, D.; Krokowski, D.; Chen, C.W.; Shu, X.E.; Chukwurah, E.; Wu, J.; Gao, Z.; et al. Adaptive translational pausing is a hallmark of the cellular response to severe environmental stress. Mol. Cell 2021, 81, 4191–4208.e4198. [Google Scholar] [CrossRef] [PubMed]
- Wei, Y.; Asbell, P.A. The core mechanism of dry eye disease is inflammation. Eye Contact Lens 2014, 40, 248–256. [Google Scholar] [CrossRef]
- Corrales, R.M.; Stern, M.E.; De Paiva, C.S.; Welch, J.; Li, D.Q.; Pflugfelder, S.C. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Investig. Ophthalmol. Vis. Sci. 2006, 47, 3293–3302. [Google Scholar] [CrossRef] [PubMed]
- Ollivier, F.J.; Brooks, D.E.; Kallberg, M.E.; Komaromy, A.M.; Lassaline, M.E.; Andrew, S.E.; Gelatt, K.N.; Stevens, G.R.; Blalock, T.D.; van Setten, G.B.; et al. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am. J. Vet. Res. 2003, 64, 1081–1087. [Google Scholar] [CrossRef]
- Jones, D.T.; Monroy, D.; Ji, Z.; Pflugfelder, S.C. Alterations of ocular surface gene expression in Sjögren’s syndrome. Adv. Exp. Med. Biol. 1998, 438, 533–536. [Google Scholar] [CrossRef]
- Inatomi, T.; Spurr-Michaud, S.; Tisdale, A.S.; Gipson, I.K. Human corneal and conjunctival epithelia express MUC1 mucin. Investig. Ophthalmol. Vis. Sci. 1995, 36, 1818–1827. [Google Scholar]
- Watanabe, H. Significance of mucin on the ocular surface. Cornea 2002, 21 (Suppl. S1), S17–S22. [Google Scholar] [CrossRef] [PubMed]
- Watanabe, H.; Fabricant, M.; Tisdale, A.S.; Spurr-Michaud, S.J.; Lindberg, K.; Gipson, I.K. Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface. Investig. Ophthalmol. Vis. Sci. 1995, 36, 337–344. [Google Scholar]
- Albertsmeyer, A.C.; Kakkassery, V.; Spurr-Michaud, S.; Beeks, O.; Gipson, I.K. Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp. Eye Res. 2010, 90, 444–451. [Google Scholar] [CrossRef]
- Bennett, J.E. The management of total xerophthalmia. Trans. Am. Ophthalmol. Soc. 1968, 66, 503–529. [Google Scholar] [CrossRef] [PubMed]
- Burg, M.B.; Ferraris, J.D.; Dmitrieva, N.I. Cellular response to hyperosmotic stresses. Physiol. Rev. 2007, 87, 1441–1474. [Google Scholar] [CrossRef] [PubMed]
- Saito, H.; Posas, F. Response to hyperosmotic stress. Genetics 2012, 192, 289–318. [Google Scholar] [CrossRef]
- Grady, C.R.; Knepper, M.A.; Burg, M.B.; Ferraris, J.D. Database of osmoregulated proteins in mammalian cells. Physiol. Rep. 2014, 2, 12180. [Google Scholar] [CrossRef]
- Alfieri, R.R.; Petronini, P.G. Hyperosmotic stress response: Comparison with other cellular stresses. Pflug. Arch. Eur. J. Physiol. 2007, 454, 173–185. [Google Scholar] [CrossRef]
- Lamichhane, P.P.; Samir, P. Cellular Stress: Modulator of Regulated Cell Death. Biology 2023, 12, 1172. [Google Scholar] [CrossRef]
- Kumar, N.R.; Praveen, M.; Narasimhan, R.; Khamar, P.; D’Souza, S.; Sinha-Roy, A.; Sethu, S.; Shetty, R.; Ghosh, A. Tear biomarkers in dry eye disease: Progress in the last decade. Indian J. Ophthalmol. 2023, 71, 1190–1202. [Google Scholar] [CrossRef] [PubMed]
- Prinz, J.; Maffulli, N.; Fuest, M.; Walter, P.; Bell, A.; Migliorini, F. Efficacy of Topical Administration of Corticosteroids for the Management of Dry Eye Disease: Systematic Review and Meta-Analysis. Life 2022, 12, 1932. [Google Scholar] [CrossRef] [PubMed]
- Ryu, K.J.; Kim, S.; Kim, M.K.; Paik, H.J.; Kim, D.H. Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker. Clin. Ophthalmol. 2021, 15, 759–767. [Google Scholar] [CrossRef]
- Donnenfeld, E.; Pflugfelder, S.C. Topical ophthalmic cyclosporine: Pharmacology and clinical uses. Surv. Ophthalmol. 2009, 54, 321–338. [Google Scholar] [CrossRef]
- Lin, X.; Wu, Y.; Tang, L.; Ouyang, W.; Yang, Y.; Liu, Z.; Wu, J.; Zheng, X.; Huang, C.; Zhou, Y.; et al. Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model. Transl. Vis. Sci. Technol. 2020, 9, 22. [Google Scholar] [CrossRef]
- Ofri, R.; Lambrou, G.N.; Allgoewer, I.; Graenitz, U.; Pena, T.M.; Spiess, B.M.; Latour, E. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: A comparison with cyclosporine A. Vet. J. 2009, 179, 70–77. [Google Scholar] [CrossRef]
- Park, J.Y.; Kim, B.G.; Kim, J.S.; Hwang, J.H. Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease. Transl. Vis. Sci. Technol. 2018, 7, 31. [Google Scholar] [CrossRef]
- Wu, W.L.; Chang, S.W. Effects of cyclosporine on steroid-refractory dry eyes. Taiwan J. Ophthalmol. 2023, 13, 306–316. [Google Scholar] [CrossRef]
- Katsuyama, I.; Arakawa, T. A convenient rabbit model of ocular epithelium damage induced by osmotic dehydration. J. Ocul. Pharmacol. Ther. 2003, 19, 281–289. [Google Scholar] [CrossRef] [PubMed]
- Balazs, E.A. Viscoelastic properties of hyaluronic acid and biological lubrication. Univ. Mich. Med. Cent. J. 1968, 255–259. [Google Scholar]
- Balazs, E.A. Interaction between cells, hyaluronic acid and collagen. Upsala J. Med. Sci. 1977, 82, 94. [Google Scholar] [CrossRef] [PubMed]
- Balazs, E.A.; Denlinger, J.L. Clinical uses of hyaluronan. Ciba Found. Symp. 1989, 143, 265–281. [Google Scholar] [CrossRef] [PubMed]
- Ang, B.C.H.; Sng, J.J.; Wang, P.X.H.; Htoon, H.M.; Tong, L.H.T. Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis. Sci. Rep. 2017, 7, 9013. [Google Scholar] [CrossRef] [PubMed]
- Aragona, P.; Simmons, P.A.; Wang, H.; Wang, T. Physicochemical Properties of Hyaluronic Acid-Based Lubricant Eye Drops. Transl. Vis. Sci. Technol. 2019, 8, 2. [Google Scholar] [CrossRef]
- Laffleur, F.; Dachs, S. Development of novel mucoadhesive hyaluronic acid derivate as lubricant for the treatment of dry eye syndrome. Ther. Deliv. 2015, 6, 1211–1219. [Google Scholar] [CrossRef]
- Lee, J.E.; Kim, S.; Lee, H.K.; Chung, T.Y.; Kim, J.Y.; Choi, C.Y.; Chung, S.H.; Kim, D.H.; Kim, K.W.; Chung, J.K.; et al. A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome. Sci. Rep. 2022, 12, 18737. [Google Scholar] [CrossRef]
- Van Setten, G.B.; Baudouin, C.; Horwath-Winter, J.; Böhringer, D.; Stachs, O.; Toker, E.; Al-Zaaidi, S.; Benitez-Del-Castillo, J.M.; Beck, R.; Al-Sheikh, O.; et al. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. J. Clin. Med. 2020, 9, 3536. [Google Scholar] [CrossRef]
- Wang, L.; Dai, W.; Lu, L. Hyperosmotic stress-induced corneal epithelial cell death through activation of Polo-like kinase 3 and c-Jun. Investig. Ophthalmol. Vis. Sci. 2011, 52, 3200–3206. [Google Scholar] [CrossRef]
- Cavet, M.E.; Harrington, K.L.; Ward, K.W.; Zhang, J.Z. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Mol. Vis. 2010, 16, 1791–1800. [Google Scholar]
- Pirkkala, L.; Nykänen, P.; Sistonen, L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 2001, 15, 1118–1131. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
van Setten, G.-B. Cellular Stress in Dry Eye Disease—Key Hub of the Vicious Circle. Biology 2024, 13, 669. https://doi.org/10.3390/biology13090669
van Setten G-B. Cellular Stress in Dry Eye Disease—Key Hub of the Vicious Circle. Biology. 2024; 13(9):669. https://doi.org/10.3390/biology13090669
Chicago/Turabian Stylevan Setten, Gysbert-Botho. 2024. "Cellular Stress in Dry Eye Disease—Key Hub of the Vicious Circle" Biology 13, no. 9: 669. https://doi.org/10.3390/biology13090669